Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles

Particuology

Volumn 10, Issue 3, 2012, Pages 327-333

  Cheow, Wean Sin ^a   Hadinoto, Kunn ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Biofilm; Calcein; Hybrid nanoparticles; Liposomes; Pseudomonas aeruginosa; Rhamnolipid; Triggered release

Indexed keywords

CALCEIN; HYBRID NANOPARTICLE; PSEUDOMONAS AERUGINOSA; RHAMNOLIPIDS; TRIGGERED RELEASE;

ADSORPTION; BACTERIA; BIOFILMS; DRUG DELIVERY; LIPOSOMES; POLYMERS;

NANOPARTICLES;

EID: 84861229301     PISSN: 16742001     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.partic.2011.08.007     Document Type: Article

References (23)

1. M. Alipour, Z.E. Suntres, M. Halwani, A.O. Azghani, and A. Omri Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis PLOS One 4 5 2009 e5724 10.1371/journal.pone. 0005724
2. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification - The correlation of in vitro drug product dissolution and in vivo bioavailability Pharmaceutical Research 12 3 1995 413 420
3. S.A. Breda, A.F. Jimenez-Kairuz, R.H. Manzo, and M.E. Olivera Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives International Journal of Pharmaceutics 371 1-2 2009 106 113
4. W.S. Cheow, M.W. Chang, and K. Hadinoto Antibacterial efficacy of inhalable levofloxacin-loaded polymeric nanoparticles against E. coli biofilm cells: The effect of antibiotic release profile Pharmaceutical Research 27 8 2010 1597 1609
5. W.S. Cheow, and K. Hadinoto Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles Colloids and Surfaces B - Biointerfaces 85 2 2011 214 220
6. M.E. Davey, N.C. Caiazza, and G.A. O'Toole Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1 Journal of Bacteriology 185 3 2003 1027 1036
7. Z. Drulis-Kawa, and A. Dorotkiewicz-Jach Liposomes as delivery systems for antibiotics International Journal of Pharmaceutics 387 1-2 2010 187 198
8. M. Halwani, S. Hebert, Z.E. Suntres, R.M. Lafrenie, A.O. Azghani, and A. Omri Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa International Journal of Pharmaceutics 373 1-2 2009 141 146
9. S.M. Jo, and J.C. Kim Glucose-triggered release from liposomes incorporating poly(N-isopropylacrylamide-co-methacrylic acid-co- octadecylacrylate) and glucose oxidase Colloid Polymer Science 287 4 2009 379 384
10. K. Kho, and K. Hadinoto Aqueous re-dispersibility characterization of spray-dried hollow spherical silica nano-aggregates Powder Technology 198 3 2010 354 363
11. K. Koga, N. Takarada, and K. Takada Nano-sized water-in-oil-in-water emulsion enhances intestinal absorption of calcein, a high solubility and low permeability compound European Journal of Pharmaceutics and Biopharmaceutics 74 2 2010 223 232
12. U. Kragh-Hansen, M. le Maire, and J.V. Moller The mechanism of detergent solubilization of liposomes and protein-containing membranes Biophysical Journal 75 6 1998 2932 2946
13. S. Litvinchuk, Z. Lu, P. Rigler, T.D. Hirt, and W. Meier Calcein release from polymeric vesicles in blood plasma and PVA hydrogel Pharmaceutical Research 26 7 2009 1711 1717
14. P. Meers, M. Neville, V. Malinin, A.W. Scotto, G. Sardaryan, and R. Kurumunda Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections Journal of Antimicrobial Chemotherapy 61 4 2008 859 868
15. C. Mugabe, M. Halwani, A.O. Azghani, R.M. Lafrenie, and A. Omri Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa Antimicrobial Agents Chemotherapy 50 6 2006 2016 2022
16. I.S. Patel, I. Vlahos, T.M.A. Wilkinson, S.J. Lloyd-Owen, G.C. Donaldson, and M. Wilks Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 170 4 2004 400 407
17. R.A. Pauwels, and K.F. Rabe Burden and clinical features of chronic obstructive pulmonary disease (COPD) Lancet 364 9434 2004 613 620
18. A.M. Robinson, M. Bannister, J.E. Creeth, and M.N. Jones The interaction of phospholipid liposomes with mixed bacterial biofilms and their use in the delivery of bactericide Colloids Surfaces A: Physicochemical and Engineering Aspects 186 1-2 2001 43 53
19. N.N. Sanders, S.C. De Smedt, E. Van Rompaey, P. Simoens, F. De Baets, and J. Demeester Cystic fibrosis sputum - A barrier to the transport of nanospheres American Journal of Respiratory and Critical Care Medicine 162 5 2000 1905 1911
20. J.S. Suk, S.K. Lai, Y.Y. Wang, L.M. Ensign, P.L. Zeitlin, and M.P. Boyle The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles Biomaterials 30 13 2009 2591 2597
21. D.A. Volpe Permeability classification of representative fluoroquinolones by a cell culture method AAPS Pharmscitech 6 2 2004 e13 10.1208/ps060213
22. S.P. Vyas, V. Sihorkar, and S. Jain Mannosylated liposomes for bio-film targeting International Journal of Pharmaceutics 330 1-2 2007 6 13
23. G.G. Zhanel, K. Ennis, L. Vercaigne, A. Walkty, A.S. Gin, and J. Embil A critical review of the fluoroquinolones - Focus on respiratory tract infections Drugs 62 1 2002 13 59